Starch Medical Inc.

Starch Medical Inc. is a San Jose, California-based medical device company specializing in the design, manufacture, and distribution of innovative, absorbable hemostatic products. The company's core technology platform, AMP® (Absorbable Modified Polymers), consists of biocompatible, ultra-hydrophilic, and adhesive polymer particles synthesized from purified plant starch to control bleeding intraoperatively and in trauma settings. AMP® materials contain no human or animal components, positioning them as a synthetic alternative to traditional hemostatic agents. The company's product portfolio includes SuperClot®, PerClot®, SealFoam®, and Responder®—all leveraging the proprietary AMP® technology platform. These products are designed to reduce bleeding-associated risks during surgical procedures and emergency trauma management. The company emphasizes sustainability and carbon footprint reduction as core operational principles. While specific regulatory certifications are not detailed in the available content, the company's focus on absorbable biomaterials and hemostatic efficacy suggests FDA 510(k) clearance pathways typical for wound-care and surgical hemostatic devices in the U.S. market.